Bio-Techne Corp (TECH)
71.88
-0.64
(-0.88%)
USD |
NASDAQ |
Mar 18, 16:00
71.88
0.00 (0.00%)
Pre-Market: 20:00
Bio-Techne Cash from Operations (TTM): 276.43M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 276.43M |
September 30, 2023 | 257.70M |
June 30, 2023 | 254.39M |
March 31, 2023 | 273.72M |
December 31, 2022 | 296.31M |
September 30, 2022 | 332.92M |
June 30, 2022 | 325.27M |
March 31, 2022 | 344.58M |
December 31, 2021 | 346.31M |
September 30, 2021 | 334.59M |
June 30, 2021 | 352.16M |
March 31, 2021 | 274.94M |
December 31, 2020 | 249.54M |
September 30, 2020 | 230.69M |
June 30, 2020 | 205.22M |
March 31, 2020 | 216.37M |
December 31, 2019 | 206.56M |
September 30, 2019 | 182.71M |
June 30, 2019 | 181.62M |
March 31, 2019 | 190.51M |
December 31, 2018 | 172.50M |
September 30, 2018 | 165.12M |
June 30, 2018 | 170.37M |
March 31, 2018 | 156.38M |
December 31, 2017 | 159.75M |
Date | Value |
---|---|
September 30, 2017 | 162.19M |
June 30, 2017 | 143.72M |
March 31, 2017 | 129.52M |
December 31, 2016 | 141.64M |
September 30, 2016 | 138.55M |
June 30, 2016 | 144.16M |
March 31, 2016 | 144.65M |
December 31, 2015 | 138.29M |
September 30, 2015 | 135.47M |
June 30, 2015 | 139.36M |
March 31, 2015 | 140.14M |
December 31, 2014 | 144.30M |
September 30, 2014 | 139.90M |
June 30, 2014 | 136.76M |
March 31, 2014 | 128.83M |
December 31, 2013 | 126.92M |
September 30, 2013 | 126.88M |
June 30, 2013 | 123.56M |
March 31, 2013 | 130.99M |
December 31, 2012 | 132.43M |
September 30, 2012 | 121.58M |
June 30, 2012 | 126.75M |
March 31, 2012 | 124.00M |
December 31, 2011 | 121.93M |
September 30, 2011 | 130.92M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
181.62M
Minimum
Jun 2019
352.16M
Maximum
Jun 2021
266.63M
Average
265.71M
Median
Cash from Operations (TTM) Benchmarks
Agilent Technologies Inc | 1.961B |
Revvity Inc | 91.27M |
Twist Bioscience Corp | -111.38M |
AIM ImmunoTech Inc | -17.58M |
Protalix BioTherapeutics Inc | -1.318M |